Bone Regeneration in the Application of a New Device for Osteosynthesis in the Experiment

Background. Treatment of residual cavities after radical surgery for bone diseases is a vital problem of modern traumatology. Currently, there is an active search for devices both for osteosynthesis and bone-substituting masses. Aims. The purpose of this work was to test a new device for osteosynthesis. It can be used both for fixing bone fragments, and for studying the morphological features of bone regenerate in experiment.Materials and methods. A device for bone osteosynthesis of tubular bones in an experiment (Patent of the Russian Federation N 20116121487) was applied. The device consisted of two half-bushings, fastened to each other by a fierce clamp. Polypropylene was used as the material for the half-bushings, therefore no immunological reactions were observed. On the inner surface there were silicone cylinders, which directed pressure on the fragments and did not disturb the nutrition of the periosteum. The experiment was performed on Wistar rats. The surgical defect of the femur was filled with hydroxyapatite. Two groups of animals were identified. The bone in the first group was fixed by the device. The wire cerclage was used in the second group.Results. The study showed that the developed device does not disturb the nutrition of the periosteum, and also tightly fixes the osteoplastic material in the bone defect. Histological examination showed that bone regeneration was faster when the device was used. On the 21st day of the experiment, the regenerate filled the defect in the control group by 62 %, and in the experimental group by 73 %. The regenerate was represented by a woven bone. In all animals, bone regenerate formed a strong osteo-integrative connection with the maternal bone. In both groups, it looked like a mature bone tissue at the end of the experiment (28 days).Conclusion. The data indicate that the device does not disturb the processes of bone formation and allows for more efficient use osteoplastic material

Effectiveness of empirical <i>Helicobacter pylori</i> eradication therapy with furazolidone in Russia: results from the European Registry on <i>Helicobacter pylori</i> Management (Hp-EuReg)

Background. First-line therapy does not always provide a high level of Helicobacter pylori eradication due to the increase of H. pylori resistance to antibiotics; therefore, it remains necessary to identify the most effective rescue treatments. The purpose of this study was to evaluate the efficacy and safety of empirical H. pylori furazolidone-containing regimens. Materials and methods. Adult H. pylori infected patients empirically treated with furazolidone-containing eradication regimens were registered in an international, prospective, multicenter non-intervention European registry on H. pylori management (Hp-EuReg). Data were collected at AEG-REDCap e-CRF from 2013 to 2021 and the quality was reviewed. Modified intention-to-treat (mITT) effectiveness analyses were performed. Results. Overall 106 patients received empirical furazolidone-containing therapy in Russia. Furazolidone was prescribed in a sequential scheme along with amoxicillin, clarithromycin and a proton pump inhibitor in 68 (64%) cases, triple regimens were prescribed in 28 (26%) patients and quadruple regimens in 10 (9.4%). Treatment duration of 7 days was assigned to 2 (1.9%) patients, 10-day eradication therapy in case of 80 (75%) and 14 days in 24 (23%) patients. Furazolidone was mainly used in first- (79%) and second-line (21%) regimens. The methods used to diagnose H. pylori infection were: histology (81%), stool antigen test (64%), 13C-urea breath test (6.6%), and rapid urease test (1.9%). The mITT effectiveness of sequential therapy was 100%; 93% with the triple therapy and 75.5% with quadruple therapy. Compliance was reported in 98% of cases. Adverse events were revealed in 5.7% of patients, mostly nausea (3.8%). No serious adverse events were reported. Conclusion. Furazolidone containing eradication regimens appear to be an effective and safe empirical therapy in Russia

Substrate specificity of new methyl-directed DNA endonuclease GlaI

<p>Abstract</p> <p>Background</p> <p>Recently, we have discovered site-specific endonucleases, which recognize and cleave only DNA sequences with 5-methylcytosine. Two specificities of such endonucleases have been described. Enzymes BisI, BlsI, and GluI are isoschizomers and hydrolyze the DNA sequence 5'-GCNGC-3'/3'-CGNCG-5', which is methylated in different ways. The enzyme GlaI cleaves the DNA sequence 5'-GCGC-3'/3'-CGCG-5' if there are two, three or four 5-methylcytosines. The goal of the present work is to study in detail the composition of recognition sequence and effect of the methylated cytosines on the efficiency of DNA cleavage by the methyl-directed DNA endonuclease GlaI</p> <p>Results</p> <p>In a recent work we have studied the dependence of GlaI activity on the quantity and location of 5-methylcytosines in the enzyme recognition sequence 5'-GCGC-3'/3'-CGCG-5'. A significant DNA cleavage has been observed for oligonucleotide duplexes, which include either three or four 5-methylcytosines. In this work we have studied dependence of the GlaI activity on quantity and location of methylated cytosines, as well as on composition of the recognition sequence.</p> <p>Conclusion</p> <p>The list of good substrates for GlaI includes a fully methylated site 5'-CGCG-3'/3'-GCGC-5', sites with three cytosines of a general structure 5'-PuMGM-3'/3'-PyGMG-5', and one recognition sequence with two methylated cytosines 5'-AMGT-3'/3'-TGMA-5', where M is 5-methylcytosine.</p> <p>GlaI intermediate substrates include sites with three methylated cytosines of a general structure 5'-GMPuM-3'/3'-MGPyG-5', as well as a site with two methylcytosines 5'-GMGT-3'/3'-CGMA-5'.</p> <p>The site 5'-GMGC-3'/3'-CGMG-5' may be considered a low activity substrate.</p

Magnetic structural effect (MSE) in epitaxial films of cerium oxide and lanthanum zirconate

Increasing the critical current density in the second generation high-temperature superconducting wires (2G HTS) is the major challenge for researchers and manufacturers of 2G HTS wires all over the world. We proposed a new approach to increase the number of percolation paths for supercurrent, i.e. increasing the number of low angle grain boundaries (<5°) in the epitaxial superconducting YBCO layer by magnetic structural processing (MSP) of buffer layers. New experimental results have been presented on the application of MSP for improving the structure and increasing the texture sharpness of buffer in electrical conducting element of 2G HTS wire. The influence of MCO on the structural and textural properties has been investigated in a buffer consisting of epitaxial films of cerium oxide CeO2 and lanthanum zirconate La2Zr2O7 in the CeO2/4La2Zr2O7 architecture. The influence of the magnetic processing of the epitaxial La2Zr2O7 buffer film on the shape of grains has been found. An atomic force microscopical study has shown that after magnetic processing the shape of grains improved significantly. A multilayer CeO2/4La2Zr2O7 buffer each layer of which was processed in a magnetic field has a high degree of orientation: only one diffraction peak with (200) indexes is observed in the X-ray spectrum. The X-ray settings of the (200) diffraction peak indicate a well developed epitaxial structure of CeO2 and La2Zr2O7 layers. The texture of the buffer is by more than 2° sharper than that of the Ni–5 at% W substrate